Literature DB >> 12915558

Involvement of the matrix and nucleocapsid domains of the bovine leukemia virus Gag polyprotein precursor in viral RNA packaging.

Huating Wang1, Kendra M Norris, Louis M Mansky.   

Abstract

The RNA packaging process for retroviruses involves a recognition event of the genome-length viral RNA by the viral Gag polyprotein precursor (PrGag), an important step in particle morphogenesis. The mechanism underlying this genome recognition event for most retroviruses is thought to involve an interaction between the nucleocapsid (NC) domain of PrGag and stable RNA secondary structures that form the RNA packaging signal. Presently, there is limited information regarding PrGag-RNA interactions involved in RNA packaging for the deltaretroviruses, which include bovine leukemia virus (BLV) and human T-cell leukemia virus types 1 and 2 (HTLV-1 and -2, respectively). To address this, alanine-scanning mutagenesis of BLV PrGag was done with a virus-like particle (VLP) system. As predicted, mutagenesis of conserved basic residues as well as residues of the zinc finger domains in the BLV NC domain of PrGag revealed residues that led to a reduction in viral RNA packaging. Interestingly, when conserved basic residues in the BLV MA domain of PrGag were mutated to alanine or glycine, but not when mutated to another basic residue, reductions in viral RNA packaging were also observed. The ability of PrGag to be targeted to the cell membrane was not affected by these mutations in MA, indicating that PrGag membrane targeting was not associated with the reduction in RNA packaging. These observations indicate that these basic residues in the MA domain of PrGag influence RNA packaging, without influencing Gag membrane localization. It was further observed that (i) a MA/NC double mutant had a more severe RNA packaging defect than either mutant alone, and (ii) RNA packaging was not found to be associated with transient localization of Gag in the nucleus. In summary, this report provides the first direct evidence for the involvement of both the BLV MA and NC domains of PrGag in viral RNA packaging.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12915558      PMCID: PMC187409          DOI: 10.1128/jvi.77.17.9431-9438.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  40 in total

Review 1.  Zinc finger peptides for the regulation of gene expression.

Authors:  A Klug
Journal:  J Mol Biol       Date:  1999-10-22       Impact factor: 5.469

2.  Secondary structure analysis of a minimal avian leukosis-sarcoma virus packaging signal.

Authors:  J D Banks; M L Linial
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

3.  RNA is a structural element in retrovirus particles.

Authors:  D Muriaux; J Mirro; D Harvin; A Rein
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-24       Impact factor: 11.205

Review 4.  In the beginning: genome recognition, RNA encapsidation and the initiation of complex retrovirus assembly.

Authors:  Nancy A Jewell; Louis M Mansky
Journal:  J Gen Virol       Date:  2000-08       Impact factor: 3.891

5.  Functional analysis of the core human immunodeficiency virus type 1 packaging signal in a permissive cell line.

Authors:  G P Harrison; G Miele; E Hunter; A M Lever
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

Review 6.  HIV-1 gag proteins: diverse functions in the virus life cycle.

Authors:  E O Freed
Journal:  Virology       Date:  1998-11-10       Impact factor: 3.616

7.  Identification of a high affinity nucleocapsid protein binding element within the Moloney murine leukemia virus Psi-RNA packaging signal: implications for genome recognition.

Authors:  V D'Souza; J Melamed; D Habib; K Pullen; K Wallace; M F Summers
Journal:  J Mol Biol       Date:  2001-11-23       Impact factor: 5.469

8.  Sequence-specific interaction between HIV-1 matrix protein and viral genomic RNA revealed by in vitro genetic selection.

Authors:  P Purohit; S Dupont; M Stevenson; M R Green
Journal:  RNA       Date:  2001-04       Impact factor: 4.942

9.  The nucleocapsid domain is responsible for the ability of spleen necrosis virus (SNV) Gag polyprotein to package both SNV and murine leukemia virus RNA.

Authors:  J L Certo; T O Kabdulov; M L Paulson; J A Anderson; W S Hu
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

10.  Nonreciprocal packaging of human immunodeficiency virus type 1 and type 2 RNA: a possible role for the p2 domain of Gag in RNA encapsidation.

Authors:  J F Kaye; A M Lever
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

View more
  32 in total

Review 1.  Features, processing states, and heterologous protein interactions in the modulation of the retroviral nucleocapsid protein function.

Authors:  Gilles Mirambeau; Sébastien Lyonnais; Robert J Gorelick
Journal:  RNA Biol       Date:  2010-11-01       Impact factor: 4.652

2.  Gag localization and virus-like particle release mediated by the matrix domain of human T-lymphotropic virus type 1 Gag are less dependent on phosphatidylinositol-(4,5)-bisphosphate than those mediated by the matrix domain of HIV-1 Gag.

Authors:  Jingga Inlora; Vineela Chukkapalli; David Derse; Akira Ono
Journal:  J Virol       Date:  2011-02-02       Impact factor: 5.103

3.  Human T-cell leukemia virus type 1 Gag domains have distinct RNA-binding specificities with implications for RNA packaging and dimerization.

Authors:  Weixin Wu; Joshua Hatterschide; Yu-Ci Syu; William A Cantara; Ruth J Blower; Heather M Hanson; Louis M Mansky; Karin Musier-Forsyth
Journal:  J Biol Chem       Date:  2018-09-14       Impact factor: 5.157

Review 4.  Diverse interactions of retroviral Gag proteins with RNAs.

Authors:  Alan Rein; Siddhartha A K Datta; Christopher P Jones; Karin Musier-Forsyth
Journal:  Trends Biochem Sci       Date:  2011-05-06       Impact factor: 13.807

5.  C-terminal domain modulates the nucleic acid chaperone activity of human T-cell leukemia virus type 1 nucleocapsid protein via an electrostatic mechanism.

Authors:  Dominic F Qualley; Kristen M Stewart-Maynard; Fei Wang; Mithun Mitra; Robert J Gorelick; Ioulia Rouzina; Mark C Williams; Karin Musier-Forsyth
Journal:  J Biol Chem       Date:  2009-11-03       Impact factor: 5.157

6.  Solution Conformation of Bovine Leukemia Virus Gag Suggests an Elongated Structure.

Authors:  Dominic F Qualley; Sarah E Cooper; James L Ross; Erik D Olson; William A Cantara; Karin Musier-Forsyth
Journal:  J Mol Biol       Date:  2019-02-04       Impact factor: 5.469

7.  Opposing mechanisms involving RNA and lipids regulate HIV-1 Gag membrane binding through the highly basic region of the matrix domain.

Authors:  Vineela Chukkapalli; Seung J Oh; Akira Ono
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-04       Impact factor: 11.205

8.  Human T-cell lymphotropic virus type 1 nucleocapsid protein-induced structural changes in transactivation response DNA hairpin measured by single-molecule fluorescence resonance energy transfer.

Authors:  Qusai Darugar; Hannah Kim; Robert J Gorelick; Christy Landes
Journal:  J Virol       Date:  2008-10-01       Impact factor: 5.103

9.  Biophysical analysis of HTLV-1 particles reveals novel insights into particle morphology and Gag stochiometry.

Authors:  Iwen F Grigsby; Wei Zhang; Jolene L Johnson; Keir H Fogarty; Yan Chen; Jonathan M Rawson; Aaron J Crosby; Joachim D Mueller; Louis M Mansky
Journal:  Retrovirology       Date:  2010-09-20       Impact factor: 4.602

Review 10.  Roles played by acidic lipids in HIV-1 Gag membrane binding.

Authors:  Balaji Olety; Akira Ono
Journal:  Virus Res       Date:  2014-07-03       Impact factor: 3.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.